Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis
Identifieur interne : 000811 ( Main/Exploration ); précédent : 000810; suivant : 000812Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis
Auteurs : Mathieu Boniol [France] ; Philippe Autier [France] ; Peter Boyle [France] ; Sara Gandini [Italie]Source :
- BMJ : British Medical Journal [ 1756-1833 ] ; 2012.
Abstract
Objective To estimate the burden of melanoma resulting from sunbed use in western Europe. Design Systematic review and meta-analysis. Data sources PubMed, ISI Web of Science (Science Citation Index Expanded), Embase, Pascal, Cochrane Library, LILACS, and MedCarib, along with published surveys reporting prevalence of sunbed use at national level in Europe. Study selection Observational studies reporting a measure of risk for skin cancer (cutaneous melanoma, squamous cell carcinoma, basal cell carcinoma) associated with ever use of sunbeds. Results Based on 27 studies ever use of sunbeds was associated with a summary relative risk of 1.20 (95% confidence interval 1.08 to 1.34). Publication bias was not evident. Restricting the analysis to cohorts and population based studies, the summary relative risk was 1.25 (1.09 to 1.43). Calculations for dose-response showed a 1.8% (95% confidence interval 0% to 3.8%) increase in risk of melanoma for each additional session of sunbed use per year. Based on 13 informative studies, first use of sunbeds before age 35 years was associated with a summary relative risk of 1.87 (1.41 to 2.48), with no indication of heterogeneity between studies. By using prevalence data from surveys and data from GLOBOCAN 2008, in 2008 in the 15 original member countries of the European Community plus three countries that were members of the European Free Trade Association, an estimated 3438 cases of melanoma could be attributable to sunbed use, most (n=2341) occurring among women. Conclusions Sunbed use is associated with a significant increase in risk of melanoma. This risk increases with number of sunbed sessions and with initial usage at a young age (<35 years). The cancerous damage associated with sunbed use is substantial and could be avoided by strict regulations.
Url:
DOI: 10.1136/bmj.e4757
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001152
- to stream Istex, to step Curation: 001128
- to stream Istex, to step Checkpoint: 000424
- to stream Main, to step Merge: 000812
- to stream Main, to step Curation: 000811
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis</title><author><name sortKey="Boniol, Mathieu" sort="Boniol, Mathieu" uniqKey="Boniol M" first="Mathieu" last="Boniol">Mathieu Boniol</name></author><author><name sortKey="Autier, Philippe" sort="Autier, Philippe" uniqKey="Autier P" first="Philippe" last="Autier">Philippe Autier</name></author><author><name sortKey="Boyle, Peter" sort="Boyle, Peter" uniqKey="Boyle P" first="Peter" last="Boyle">Peter Boyle</name></author><author><name sortKey="Gandini, Sara" sort="Gandini, Sara" uniqKey="Gandini S" first="Sara" last="Gandini">Sara Gandini</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:6C6BC6BC39D6AEF5892EADFD034CF588CD92867A</idno><date when="2012" year="2012">2012</date><idno type="doi">10.1136/bmj.e4757</idno><idno type="url">https://api.istex.fr/document/6C6BC6BC39D6AEF5892EADFD034CF588CD92867A/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001152</idno><idno type="wicri:Area/Istex/Curation">001128</idno><idno type="wicri:Area/Istex/Checkpoint">000424</idno><idno type="wicri:Area/Main/Merge">000812</idno><idno type="wicri:Area/Main/Curation">000811</idno><idno type="wicri:Area/Main/Exploration">000811</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis</title><author><name sortKey="Boniol, Mathieu" sort="Boniol, Mathieu" uniqKey="Boniol M" first="Mathieu" last="Boniol">Mathieu Boniol</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>International Prevention Research Institute, 95 cours Lafayette, 69006 Lyon</wicri:regionArea><placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region><region type="old region" nuts="2">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation><affiliation></affiliation></author><author><name sortKey="Autier, Philippe" sort="Autier, Philippe" uniqKey="Autier P" first="Philippe" last="Autier">Philippe Autier</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>International Prevention Research Institute, 95 cours Lafayette, 69006 Lyon</wicri:regionArea><placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region><region type="old region" nuts="2">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Boyle, Peter" sort="Boyle, Peter" uniqKey="Boyle P" first="Peter" last="Boyle">Peter Boyle</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>International Prevention Research Institute, 95 cours Lafayette, 69006 Lyon</wicri:regionArea><placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region><region type="old region" nuts="2">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Gandini, Sara" sort="Gandini, Sara" uniqKey="Gandini S" first="Sara" last="Gandini">Sara Gandini</name><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>European Institute of Oncology, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">BMJ : British Medical Journal</title><title level="j" type="abbrev">BMJ</title><idno type="eISSN">1756-1833</idno><imprint><publisher>British Medical Journal Publishing Group</publisher><date type="published" when="2012">2012</date><biblScope unit="volume">345</biblScope></imprint></series><idno type="istex">6C6BC6BC39D6AEF5892EADFD034CF588CD92867A</idno><idno type="DOI">10.1136/bmj.e4757</idno><idno type="href">bmj-345-bmj-e4757.pdf</idno><idno type="ArticleID">bonm003754</idno><idno type="local">bmj;345/jul24_2/e4757</idno></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Objective To estimate the burden of melanoma resulting from sunbed use in western Europe. Design Systematic review and meta-analysis. Data sources PubMed, ISI Web of Science (Science Citation Index Expanded), Embase, Pascal, Cochrane Library, LILACS, and MedCarib, along with published surveys reporting prevalence of sunbed use at national level in Europe. Study selection Observational studies reporting a measure of risk for skin cancer (cutaneous melanoma, squamous cell carcinoma, basal cell carcinoma) associated with ever use of sunbeds. Results Based on 27 studies ever use of sunbeds was associated with a summary relative risk of 1.20 (95% confidence interval 1.08 to 1.34). Publication bias was not evident. Restricting the analysis to cohorts and population based studies, the summary relative risk was 1.25 (1.09 to 1.43). Calculations for dose-response showed a 1.8% (95% confidence interval 0% to 3.8%) increase in risk of melanoma for each additional session of sunbed use per year. Based on 13 informative studies, first use of sunbeds before age 35 years was associated with a summary relative risk of 1.87 (1.41 to 2.48), with no indication of heterogeneity between studies. By using prevalence data from surveys and data from GLOBOCAN 2008, in 2008 in the 15 original member countries of the European Community plus three countries that were members of the European Free Trade Association, an estimated 3438 cases of melanoma could be attributable to sunbed use, most (n=2341) occurring among women. Conclusions Sunbed use is associated with a significant increase in risk of melanoma. This risk increases with number of sunbed sessions and with initial usage at a young age (<35 years). The cancerous damage associated with sunbed use is substantial and could be avoided by strict regulations.</div></front></TEI><affiliations><list><country><li>France</li><li>Italie</li></country><region><li>Auvergne-Rhône-Alpes</li><li>Lombardie</li><li>Rhône-Alpes</li></region><settlement><li>Lyon</li><li>Milan</li></settlement></list><tree><country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Boniol, Mathieu" sort="Boniol, Mathieu" uniqKey="Boniol M" first="Mathieu" last="Boniol">Mathieu Boniol</name></region><name sortKey="Autier, Philippe" sort="Autier, Philippe" uniqKey="Autier P" first="Philippe" last="Autier">Philippe Autier</name><name sortKey="Boyle, Peter" sort="Boyle, Peter" uniqKey="Boyle P" first="Peter" last="Boyle">Peter Boyle</name></country><country name="Italie"><region name="Lombardie"><name sortKey="Gandini, Sara" sort="Gandini, Sara" uniqKey="Gandini S" first="Sara" last="Gandini">Sara Gandini</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Belgique/explor/OpenAccessBelV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000811 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000811 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Belgique
|area= OpenAccessBelV2
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:6C6BC6BC39D6AEF5892EADFD034CF588CD92867A
|texte= Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis
}}
| This area was generated with Dilib version V0.6.25. |  |